Seroatlas · Human Serome Atlas

CEBPD

CCAAT/enhancer-binding protein delta

Also known as: C/EBP-delta, CEBPD_HUMAN, CELF, CRP3, NF-IL6-beta

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P49716
Gene
CEBPD
Ensembl
ENSG00000221869
Chromosome
8
Canonical length
269 aa
Protein class
Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses, and may be involved in the regulation of genes associated with activation and/or differentiation of macrophages. The cytogenetic location of this locus has been reported as both 8p11 and 8q11. [provided by RefSeq, Sep 2010]

Canonical amino-acid sequenceUniProt

269 residues, UniProt reviewed canonical sequence.

>P49716|CEBPD
     1  MSAALFSLDG PARGAPWPAE PAPFYEPGRA GKPGRGAEPG ALGEPGAAAP AMYDDESAID
    61  FSAYIDSMAA VPTLELCHDE LFADLFNSNH KAGGAGPLEL LPGGPARPLG PGPAAPRLLK
   121  REPDWGDGDA PGSLLPAQVA ACAQTVVSLA AAGQPTPPTS PEPPRSSPRQ TPAPGPAREK
   181  SAGKRGPDRG SPEYRQRRER NNIAVRKSRD KAKRRNQEMQ QKLVELSAEN EKLHQRVEQL
   241  TRDLAGLRQF FKQLPSPPFL PAAGTADCR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CEBPD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.65
Highest tissue expression
475 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 475 nTPM
  • ovary: 468 nTPM
  • adipose tissue: 441 nTPM
  • liver: 360 nTPM
  • breast: 305 nTPM
  • urinary bladder: 305 nTPM

Single-cell type

  • epididymal basal cells: 1,717 nCPM
  • neutrophils: 1,640 nCPM
  • fallopian secretory cells: 1,553 nCPM
  • smooth muscle cells: 1,325 nCPM
  • pericytes: 1,320 nCPM
  • alveolar cells type 2: 1,158 nCPM

Immune cell

  • neutrophil: 55 nTPM
  • classical monocyte: 20 nTPM
  • eosinophil: 11 nTPM
  • intermediate monocyte: 8.4 nTPM
  • myeloid DC: 7.4 nTPM
  • MAIT T-cell: 6.2 nTPM

Brain region

  • medulla oblongata: 157 nTPM
  • hypothalamus: 121 nTPM
  • pons: 91 nTPM
  • midbrain: 90 nTPM
  • thalamus: 86 nTPM
  • spinal cord: 85 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.98
gnomAD pLI
0.61
gnomAD missense Z
0.32
DepMap mean gene effect
-0.17
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CEBPD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CEBPD as an antibody target. Whether an autoantibody or antibody against CEBPD could matter depends on whether native CEBPD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CEBPD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CEBPD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CEBPD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...